204 related articles for article (PubMed ID: 25670515)
21. Clinical Implications of Opioid Pharmacogenomics in Patients With Cancer.
Bell GC; Donovan KA; McLeod HL
Cancer Control; 2015 Oct; 22(4):426-32. PubMed ID: 26678969
[TBL] [Abstract][Full Text] [Related]
22. Opioid pharmacokinetic drug-drug interactions.
Overholser BR; Foster DR
Am J Manag Care; 2011 Sep; 17 Suppl 11():S276-87. PubMed ID: 21999760
[TBL] [Abstract][Full Text] [Related]
23. Genetic factors in pain and its treatment.
Stamer UM; Stüber F
Curr Opin Anaesthesiol; 2007 Oct; 20(5):478-84. PubMed ID: 17873601
[TBL] [Abstract][Full Text] [Related]
24. The role of hydromorphone and OPRM1 in postoperative pain relief with hydrocodone.
Boswell MV; Stauble ME; Loyd GE; Langman L; Ramey-Hartung B; Baumgartner RN; Tucker WW; Jortani SA
Pain Physician; 2013; 16(3):E227-35. PubMed ID: 23703421
[TBL] [Abstract][Full Text] [Related]
25. [Interaction of opioid analgesics at the level of biotransformation].
Petri H; Grandt D
Schmerz; 2016 Dec; 30(6):519-525. PubMed ID: 27439327
[TBL] [Abstract][Full Text] [Related]
26. Meta-analysis of the relevance of the OPRM1 118A>G genetic variant for pain treatment.
Walter C; Lötsch J
Pain; 2009 Dec; 146(3):270-275. PubMed ID: 19683391
[TBL] [Abstract][Full Text] [Related]
27. The pharmacogenetics of opioid therapy in the management of postpartum pain: a systematic review.
Baber M; Bapat P; Nichol G; Koren G
Pharmacogenomics; 2016; 17(1):75-93. PubMed ID: 26652709
[TBL] [Abstract][Full Text] [Related]
28. The hypoalgesic effect of tramadol in relation to CYP2D6.
Poulsen L; Arendt-Nielsen L; Brøsen K; Sindrup SH
Clin Pharmacol Ther; 1996 Dec; 60(6):636-44. PubMed ID: 8988065
[TBL] [Abstract][Full Text] [Related]
29. Opioid genetics: the key to personalized pain control?
Branford R; Droney J; Ross JR
Clin Genet; 2012 Oct; 82(4):301-10. PubMed ID: 22780883
[TBL] [Abstract][Full Text] [Related]
30. Genetic modulation of the pharmacological treatment of pain.
Lötsch J; Geisslinger G; Tegeder I
Pharmacol Ther; 2009 Nov; 124(2):168-84. PubMed ID: 19615406
[TBL] [Abstract][Full Text] [Related]
31. Evolving knowledge of opioid genetics in cancer pain.
Droney J; Riley J; Ross JR
Clin Oncol (R Coll Radiol); 2011 Aug; 23(6):418-28. PubMed ID: 21612899
[TBL] [Abstract][Full Text] [Related]
32. Opioid genetics in the context of opioid switching.
Droney J; Riley J; Ross J
Curr Opin Support Palliat Care; 2012 Mar; 6(1):10-6. PubMed ID: 22228031
[TBL] [Abstract][Full Text] [Related]
33. The analgesic effect of tramadol after intravenous injection in healthy volunteers in relation to CYP2D6.
Enggaard TP; Poulsen L; Arendt-Nielsen L; Brøsen K; Ossig J; Sindrup SH
Anesth Analg; 2006 Jan; 102(1):146-50. PubMed ID: 16368820
[TBL] [Abstract][Full Text] [Related]
34. OCT1 pharmacogenetics in pain management: is a clinical application within reach?
Tzvetkov MV
Pharmacogenomics; 2017 Nov; 18(16):1515-1523. PubMed ID: 29061087
[TBL] [Abstract][Full Text] [Related]
35. Predicted activity of UGT2B7, ABCB1, OPRM1, and COMT using full-gene haplotypes and their association with the CYP2D6-inferred metabolizer phenotype.
Wendt FR; Sajantila A; Budowle B
Forensic Sci Int Genet; 2018 Mar; 33():48-58. PubMed ID: 29190510
[TBL] [Abstract][Full Text] [Related]
36. Cross-sectional analysis of the influence of currently known pharmacogenetic modulators on opioid therapy in outpatient pain centers.
Lötsch J; von Hentig N; Freynhagen R; Griessinger N; Zimmermann M; Doehring A; Rohrbacher M; Sittl R; Geisslinger G
Pharmacogenet Genomics; 2009 Jun; 19(6):429-36. PubMed ID: 19514130
[TBL] [Abstract][Full Text] [Related]
37. Opioid regimens in patients with chronic pain with multiple cytochrome P450 defects.
Tennant F
J Opioid Manag; 2015; 11(3):237-42. PubMed ID: 25985808
[TBL] [Abstract][Full Text] [Related]
38. Feasibility and Utility of the Individualized Hydrocodone Therapy Based on Phenotype, Pharmacogenetics, and Pharmacokinetic Dosing.
Ruan X; Bumgarner GW; Labrie-Brown C; Kaye AD
Clin J Pain; 2016 Dec; 32(12):1105-1106. PubMed ID: 26889610
[No Abstract] [Full Text] [Related]
39. Tramadol--the impact of its pharmacokinetic and pharmacodynamic properties on the clinical management of pain.
Klotz U
Arzneimittelforschung; 2003; 53(10):681-7. PubMed ID: 14650359
[TBL] [Abstract][Full Text] [Related]
40. Codeine and oxycodone use in patients with chronic rheumatic disease pain.
Ytterberg SR; Mahowald ML; Woods SR
Arthritis Rheum; 1998 Sep; 41(9):1603-12. PubMed ID: 9751092
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
